Validation of the statistical parameters and model selection criteria of the benchmark dose methods for the evaluation of various endpoints in repeated-dose toxicity studies-Reference-Cited by-同舟云学术

Validation of the statistical parameters and model selection criteria of the benchmark dose methods for the evaluation of various endpoints in repeated-dose toxicity studies

Published:2019 Issue:4 Volume:6 Page:125-136
ISSN:2189-115X
Container-title:Fundamental Toxicological Sciences
language:en
Short-container-title:Fundam. Toxicol. Sci.

Author:

Matsumoto Mariko¹,Hirata-Koizumi Mutsuko¹,Kawamura Tomoko¹,Sakuratani Sawako¹,Ono Atsushi²,Hirose Akihiko¹

Affiliation:

1. Division of Risk Assessment, Biological Safety Research Center, National Institute of Health Sciences

2. Division of Pharmaceutical, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University

Publisher

Japanese Society of Toxicology

Link

https://www.jstage.jst.go.jp/article/fts/6/4/6_125/_pdf

Reference11 articles.

1. EFSA (2009): SCIENTIFIC OPINION: Use of the benchmark dose approach in risk assessment1 Guidance of the Scientific Committee (Question No EFSA-Q-2005-232) Adopted on 26 May 2009

2. EFSA (2011): TECHNICAL REPORT: Use of BMDS and PROAST software packages by EFSA Scientific Panels and Units for applying the Benchmark Dose (BMD) approach in risk assessment.

3. EPA (2000): Benchmark dose technical guidance document, External Review Draft, EPA/630/R-00/001. Risk Assessment Forum, US Environmental Protection Agency, Washington, DC 20460, October 2000.

4. EPA (2012): Benchmark dose technical guidance, EPA/100/R-12/001, Risk Assessment Forum, US Environmental Protection Agency, Washington DC, June 2012.

5. EPA (2018): Benchmark Dose Software (BMDS) Versuib 3.0 User Guide.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simulation-based assessment of model selection criteria during the application of benchmark dose method to quantal response data;Theoretical Biology and Medical Modelling;2020-08-05

2. Initial hazard assessment of 1,4-dichlorobutane: Genotoxicity tests, 28-day repeated-dose toxicity test, and reproductive/developmental toxicity screening test in rats;Regulatory Toxicology and Pharmacology;2020-04